Molecular radiotherapy -- the radionuclide raffle?

Gaze, M. N.; Flux, G. D.
December 2010
British Journal of Radiology;Dec2010, Vol. 83 Issue 996, p995
Academic Journal
In this article, the author discusses the efficiency of unsealed radioactive sources for the treatment of cancer and other conditions. The sources include the isotope treatment, unsealed source therapy and the molecular radiotherapy (MRT). With this, it explains thoroughly the lack of place of MRT in the management of cancers despite the extensive high-quality research that underlies it use. Also, the complexity of MRT makes it use not viable to physicians and clinicians.


Related Articles

  • Peacetime Bomb.  // Time;11/19/1951, Vol. 58 Issue 21, p56 

    The article features the cobalt bomb, the newest treatment against cancer.

  • Post-therapy whole-body scan with abnormal radioactive iodine localized to the head of two women. Lee, Stephanie L. // Endocrine Today;Jan2011, Vol. 9 Issue 1, p19 

    This article discusses the case of a young woman who received radioactive iodine remnant ablation for multifocal micropapillary thyroid carcinoma.

  • Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3). Sieger, Stephanie; Jiang, Shiming; Schönsiegel, Frank; Eskerski, Helmut; Kübler, Wolfgang; Altmann, Annette; Haberkorn, Uwe // European Journal of Nuclear Medicine & Molecular Imaging;2003, Vol. 30 Issue 5, p748 

    Abstract. Targeted transfer of a functionally active sodium iodide symporter (NIS) into tumour cells may be used for radioiodine therapy of cancer. Therefore, we investigated radioiodine uptake in a hepatoma cell line in vitro and in vivo after transfer of the sodium iodide sym-porter (hNIS)...

  • Phase I clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol. Fujiyama, S.; Shibata, J.; Maeda, S.; Tanaka, M.; Noumaru, S.; Sato, K.; Tomita, K. // British Journal of Cancer;11/3/2003, Vol. 89 Issue 9, p1614 

    SM-11355 is a platinum complex developed to treat hepatocellular carcinoma (HCC). It is administered via the hepatic artery, using a carrier, lipiodol, that consists of ethyl esters of iodized poppy seed oil. We have performed a phase I clinical trial of an SM-11355-lipiodol formulation in 11...

  • 'Rural proofing' - a key strategy for NZRGPN. Scott-Jones, Jo // New Zealand Doctor;12/17/2014, p32 

    The article offers information on the stance of the organization New Zealand Rural General Practice Network (NZRGPN) on development of rural proofing in the country.

  • Glitazone pretreatment boosted 1-131 uptake. Foster, Melissa // Endocrine Today;Dec2011, Vol. 9 Issue 12, p24 

    The article reports on a study which found that a short course of treatment with glitazone before radioiodine ablation enhances the uptake of radioactive iodine by cancer cells which could improve the treatment of metastatic differentiated thyroid cancer.

  • Reply. Sabri, O. // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 3, p394 

    Replies to a comment made on an article about the treatment of differentiated nonmedullary thyroid carcinoma. Effect of thyroid uptake of a second application of radioiodine; Results of a reduction in thyroid uptake; Difficulty in quantifying how much of the administered radioiodine is absorbed...

  • Evidence supports optional use of RAI for papillary thyroid cancer. Calabro, Anthony; Costa, Samantha; Foster, Melissa // Endocrine Today;Oct2012, Vol. 10 Issue 10, p16 

    The article reports that Iain J. Nixon, MBCHB, clinical fellow in the head and neck surgery department of Memorial Sloan-Kettering Cancer Center, has argued for the optional use of radioactive iodine for the management of papillary thyroid cancer.

  • Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany. Hoelzer, Simon; Steiner, Dagmar; Bauer, Richard; Reiners, Christoph; Farahati, Jamshid; Hundahl, Scott A.; Dudeck, Joachim // European Journal of Nuclear Medicine;2000, Vol. 27 Issue 10, p1465 

    Abstract. This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the "real-world" practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics